La Jolla Pharmaceutical Company LJPC was a big mover last session, as the company saw its shares rise over 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This …
Today, our research desk covers a blog story on LJPC. Go directly to your stock of interest and access today's free …
After announcing that its phase 3 ATHOS-3 study would be published in a prestigious medical journal, clinical-stage biotech La Jolla Pharmaceutical (NASDAQ: LJPC) saw its shares ... David and Tom Gardner have a stock tip, it can …
For more information, get Portfolio Grader’s complete analysis of LJPC stock. Louis Navellier’s ... Article printed from InvestorPlace Media, https://investorplace.com/2016/03/5-stocks-with-ugly-earnings-momentum-jasn-qrvo-codi …
SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company (Nasdaq: LJPC) (“La Jolla” or the “Company), …
Only 23% of the 158 placebo-treated patients had a blood pressure response compared to 70% of the 163 LJPC-501-treated patients. La Jolla Pharmaceutical gapped up sharply Monday and climbed during the first 45 minutes of trade. …
Investors in La Jolla Pharmaceutical Company LJPC need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 16th, 2017 $20 Put had some of the highest implied volatility of all …
Bluebird Bio Inc (BLUE): BLUE stock is down 18.29% today. Halozyme Therapeutics (HALO): HALO stock is down 16.03% today. La Jolla Pharma (LJPC): LJPC stock is down 14.81% today. Carbylan Therapeutics Inc (CBYL): CBYL …